Tetsuro Ohmori
 Professor
                            Faculty of Medicine                                                        
University of Tokushima
                                                        Japan
                        
Biography
Tetsuro Ohmori has done his MD from Hokkaido University in 1993. Currently he is working as Professor in Faculty of Medicine in Tokushima University. His research interests are Psychiatry, Psychopharmacology. Several papers of his work were published in reputed international journals. He is the member of The Japanese Society of Psychiatry and Neurology, Japanese Society of Biological Psychiatry, The Japanese Society of Clinical Neuropsychopharmacology, Japanese Society for Psychiatric Diagnosis, The Japanese society for Neurochemistry, Japanese Society of Psychosomatic Medicine.
Research Interest
Psychiatry, Psychopharmacology, Psychopharmacological and molecular medical research of mood disorders and schizophrenia.
Publications
- 
                            T Takeda, Satsuki Sumitani, S Hamatani, Y Yokose, M Shikata and Tetsuro Ohmori. Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive-compulsive disorder. Neuropsychiatric Disease and Treatment. 2017, 23(13): 577-583. 
- 
                            Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, H Yamamori, Y Yasuda, M Fujimoto, Shinya Watanabe, Hidehiro Umehara, S Shimodera, T Nakazawa, M Kikuchi, A. Nakaya, H Hashimoto, I Imoto, R Hashimoto and Tetsuro Ohmori. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences. 2017, 18(3): e632. 
- 
                            Hidehiro Umehara, Shusuke Numata, Shinya Watanabe, Yutaka Hatakeyama, Makoto Kinoshita, Yukiko Tomioka, Kiyoshi Nakahara, Takeshi Nikawa and Tetsuro Ohmori. Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder. Scientific Reports. 2017, 7(1): 4855. 

